Four proven approaches stabilizing clinical operations help health systems improve staffing stability and care delivery amid workforce constraints.

Artificial intelligence will radically transform the healthcare industry in the coming years. As AI and machine learning capabilities advance, new emerging applications promise to enhance clinical ...

Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s ...

Anita Nelsen is the senior vice president of clinical trial operations at Allucent, a global CRO focused on small and mid-sized biotech companies that offers a full spectrum of integrated services to ...

This article was written for our sponsor, BioCryst Pharmaceuticals. Clinical trials allow patients access to investigational therapies that aren’t yet available to the general public. While there’s no ...

Hospitals and health systems across the U.S. are making room in their C-suites for a new physician- and nurse-focused role: chief clinical operations officer. Chief medical officers and chief nursing ...

Many of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical ...

T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the appointment of Rebeca Villarreal-Barragan, MBA, as ...

Can clinical trials be faster and better? Yes. Here’s how. Put six life science researchers in a room and it’s likely that there will be six different opinions on almost any subject except one: that ...

Curebase, a San Francisco-based clinical trial company, has let go of an undetermined number of employees in a pivot away from decentralized and hybrid clinical trials to focus on software products.

David Zaas is the new CEO of Atrium Health Wake Forest Baptist, effective Jan. 1, 2026. He will lead clinical operations and academic alignment.